专利快速检索-快速检索全球专利，免费商用专利数据库-IPRDB

1. 发明申请

US20080319060A1 COMPOSITION CONTAINING VITAMIN C 有权
标题翻译：维生素C的组合物
公开(公告)号：US20080319060A1
公开(公告)日：2008-12-25
申请号：US11951087
申请日：2007-12-05
申请人： Min Hee Choi , Gi Woong Ahn , Byoung Kee Jo
发明人： Min Hee Choi , Gi Woong Ahn , Byoung Kee Jo
IPC分类号： A61K31/341
CPC分类号： A61K8/496 , A61K8/676 , A61K8/736 , A61K31/341 , A61K2800/52 , A61Q19/00
摘要： The present invention relates to a composition containing vitamin C. The composition according to the present invention includes cationic material and anionic material as a primary stabilizing agent of the vitamin C; and a caffeic acid derivative as a secondary stabilizing agent of the vitamin C. The caffeic acid derivative is water-soluble and, preferably, a new caffiec acid derivative as denoted by the chemical formula 1 below is used. According to the present invention, the cationic material and the anionic material generate an electrical double layer to stabilize the vitamin C primarily; water-soluble caffeic acid derivative stabilizes the vitamin C secondarily. Accordingly, the vitamin C is stabilized double so that the vitamin C is protected from being oxidized by air, heat and moisture.
摘要翻译：本发明涉及含有维生素C的组合物。本发明的组合物包括作为维生素C的主要稳定剂的阳离子材料和阴离子材料; 和作为维生素C的二次稳定剂的咖啡酸衍生物。咖啡酸衍生物是水溶性的，优选使用由下述化学式1表示的新的氯虫酸衍生物。根据本发明，阳离子材料和阴离子材料主要产生电气双层以稳定维生素C. 水溶性咖啡酸衍生物二次稳定维生素C。因此，维生素C被稳定为双倍，使得维生素C被保护免受空气，热和湿气的氧化。

2. 发明申请

US20070292406A1 PHARMACEUTICAL COMPOSITION FOR PREVENTING AND TREATING RESTENOSIS COMPRISING PEROXIREDOXIN 2 PROTEIN AS AN ACTIVE INGREDIENT AND COMPOSITION FOR SCREENING THERAPEUTICS OF RESTENOSIS COMPRISING PEROXIREDOXIN 2 GENE OR ITS PROTEIN PRODUCT, AND METHOD FOR SCREENING THERAPEUTICS OF RESTENOSIS USING SAID COMPOSITION 有权
标题翻译：用于预防和治疗包含过氧化二环素2蛋白作为活性成分和组合物的抑制剂的药物组合物，用于筛选包含过氧化物素2基因或其蛋白质产物的抑制剂治疗剂的组合物，以及使用合适的组合物筛选治疗效果的方法
公开(公告)号：US20070292406A1
公开(公告)日：2007-12-20
申请号：US11832597
申请日：2007-08-01
申请人： Sang-Won KANG , Min-Hee Choi
发明人： Sang-Won KANG , Min-Hee Choi
IPC分类号： A61K38/44
CPC分类号： A61K38/44 , C12Q1/28 , C12Y111/01015 , G01N2500/00 , G01N2800/323
摘要： Disclosed herein is a pharmaceutical composition for the prophylaxis and treatment of restenosis, comprising a peroxiredoxin 2 (Prx II) protein as an active ingredient. Optionally, the composition may contain other active ingredients suppressive of restenosis at the carotid artery, the coronary artery, the peripheral artery, and the renal artery. Also, a composition and a method are provided for screening therapeutics for restenosis. This screening composition comprises a peroxiredoxin 2 gene or protein. Together with the method, the composition is useful for searching and developing therapeutics for restenosis.
摘要翻译：本文公开了一种用于预防和治疗再狭窄的药物组合物，其包含过氧氧化还原蛋白2（Prx II）蛋白作为活性成分。任选地，组合物可以含有抑制颈动脉，冠状动脉，外周动脉和肾动脉再狭窄的其它活性成分。此外，提供了用于筛选再狭窄治疗剂的组合物和方法。该筛选组合物包含过氧氧化还原酶2基因或蛋白质。与该方法一起，该组合物可用于搜索和开发用于再狭窄的治疗剂。

3. 发明授权

US07794708B2 Pharmaceutical composition for preventing and treating restenosis comprising peroxiredoxin 2 protein as an active ingredient and composition for screening therapeutics of restenosis comprising peroxiredoxin 2 gene or its protein product, and method for screening therapeutics of restinosis using said composition 有权
标题翻译：用于预防和治疗再狭窄的药物组合物，其包含过氧氧化还原蛋白2蛋白作为活性成分，以及用于筛选包含过氧化物毒素2基因或其蛋白质产物的再狭窄治疗剂的组合物，以及使用所述组合物筛选再狭窄治疗剂的方法
公开(公告)号：US07794708B2
公开(公告)日：2010-09-14
申请号：US11832597
申请日：2007-08-01
申请人： Sang-Won Kang , Min-Hee Choi
发明人： Sang-Won Kang , Min-Hee Choi
IPC分类号： A61K38/43 , A61K38/44
CPC分类号： A61K38/44 , C12Q1/28 , C12Y111/01015 , G01N2500/00 , G01N2800/323
摘要： Disclosed herein is a pharmaceutical composition for the prophylaxis and treatment of restenosis, comprising a peroxiredoxin 2 (Prx II) protein as an active ingredient. Optionally, the composition may contain other active ingredients suppressive of restenosis at the carotid artery, the coronary artery, the peripheral artery, and the renal artery. Also, a composition and a method are provided for screening therapeutics for restenosis. This screening composition comprises a peroxiredoxin 2 gene or protein. Together with the method, the composition is useful for searching and developing therapeutics for restenosis.
摘要翻译：本文公开了一种用于预防和治疗再狭窄的药物组合物，其包含过氧氧化还原蛋白2（Prx II）蛋白作为活性成分。任选地，组合物可以含有抑制颈动脉，冠状动脉，外周动脉和肾动脉再狭窄的其它活性成分。此外，提供了用于筛选再狭窄治疗剂的组合物和方法。该筛选组合物包含过氧氧化还原酶2基因或蛋白质。与该方法一起，该组合物可用于搜索和开发用于再狭窄的治疗剂。

4. 发明授权

US08022090B2 Vitamin C composition stabilized with cationic material, anionic material and caffeic acid derivative 有权
标题翻译：维生素C组合物用阳离子材料，阴离子材料和咖啡酸衍生物稳定
公开(公告)号：US08022090B2
公开(公告)日：2011-09-20
申请号：US11951087
申请日：2007-12-05
申请人： Min Hee Choi , Gi Woong Ahn , Byoung Kee Jo
发明人： Min Hee Choi , Gi Woong Ahn , Byoung Kee Jo
IPC分类号： A61K31/41 , A61K31/4155 , C07D249/08
CPC分类号： A61K8/496 , A61K8/676 , A61K8/736 , A61K31/341 , A61K2800/52 , A61Q19/00
摘要： The present invention relates to a composition containing vitamin C. The composition according to the present invention includes cationic material and anionic material as a primary stabilizing agent of the vitamin C; and a caffeic acid derivative as a secondary stabilizing agent of the vitamin C. The caffeic acid derivative is water-soluble and, preferably, a new caffiec acid derivative as denoted by the chemical formula 1 below is used. According to the present invention, the cationic material and the anionic material generate an electrical double layer to stabilize the vitamin C primarily; water-soluble caffeic acid derivative stabilizes the vitamin C secondarily. Accordingly, the vitamin C is stabilized double so that the vitamin C is protected from being oxidized by air, heat and moisture.
摘要翻译：本发明涉及含有维生素C的组合物。本发明的组合物包括作为维生素C的主要稳定剂的阳离子材料和阴离子材料; 和作为维生素C的二次稳定剂的咖啡酸衍生物。咖啡酸衍生物是水溶性的，优选使用由下述化学式1表示的新的氯虫酸衍生物。根据本发明，阳离子材料和阴离子材料主要产生电气双层以稳定维生素C. 水溶性咖啡酸衍生物二次稳定维生素C。因此，维生素C被稳定为双倍，使得维生素C被保护免受空气，热和湿气的氧化。

5. 发明申请

US20120183699A1 METHOD FOR FABRICATING FLEXIBLE BOARD USING SOLUTION PROCESS 审中-公开
标题翻译：使用解决方案制造柔性板的方法
公开(公告)号：US20120183699A1
公开(公告)日：2012-07-19
申请号：US13498473
申请日：2010-02-02
申请人： Jin Jang , Min Hee Choi , Seung Hoon Han
发明人： Jin Jang , Min Hee Choi , Seung Hoon Han
IPC分类号： B05D1/36 , B05D7/00 , B82Y40/00
CPC分类号： B29C41/36 , B29C41/085 , B29C41/12 , B29C41/14 , B29C41/22 , B29K2105/167 , B29L2007/00 , B29L2031/3425 , B82Y30/00
摘要： Disclosed is a method for fabricating a flexible board using carbon nanotubes. The method includes applying a carbon nanotube-containing ink onto a substrate to form a deposited layer, and coating a polymeric or monomeric solution on the deposited carbon nanotube layer to form a thin film layer. In accordance with the method, the spin-coated carbon nanotube layer is coated with the polymeric or monomeric chemical solution to minimize an area where the base substrate contacts the polymeric film and thereby to advantageously form a flexible board readily separable from the substrate without applying any external stress or laser.
摘要翻译：公开了一种使用碳纳米管制造柔性板的方法。该方法包括将含碳纳米管的油墨施加到基板上以形成沉积层，并在沉积的碳纳米管层上涂覆聚合物或单体溶液以形成薄膜层。根据该方法，旋涂的碳纳米管层被涂覆有聚合物或单体化学溶液以最小化基底基材与聚合物膜接触的面积，从而有利地形成易于与基材分离的柔性板，而不施加任何外部应力或激光。

6. 发明申请

US20100226905A9 PHARMACEUTICAL COMPOSITION FOR PREVENTING AND TREATING RESTENOSIS COMPRISING PEROXIREDOXIN 2 PROTEIN AS AN ACTIVE INGREDIENT AND COMPOSITION FOR SCREENING THERAPEUTICS OF RESTENOSIS COMPRISING PEROXIREDOXIN 2 GENE OR ITS PROTEIN PRODUCT, AND METHOD FOR SCREENING TH 有权
标题翻译：用于预防和治疗包含过氧化二环素2蛋白作为活性成分和组合物的抑制剂的组合物，用于筛选包含过氧化物酶2基因或其蛋白质产物的抑制剂的治疗剂，以及用于筛选TH的方法
公开(公告)号：US20100226905A9
公开(公告)日：2010-09-09
申请号：US11832597
申请日：2007-08-01
申请人： Sang-Won KANG , Min-Hee Choi
发明人： Sang-Won KANG , Min-Hee Choi
IPC分类号： A61K38/44
CPC分类号： A61K38/44 , C12Q1/28 , C12Y111/01015 , G01N2500/00 , G01N2800/323
摘要： Disclosed herein is a pharmaceutical composition for the prophylaxis and treatment of restenosis, comprising a peroxiredoxin 2 (Prx II) protein as an active ingredient. Optionally, the composition may contain other active ingredients suppressive of restenosis at the carotid artery, the coronary artery, the peripheral artery, and the renal artery. Also, a composition and a method are provided for screening therapeutics for restenosis. This screening composition comprises a peroxiredoxin 2 gene or protein. Together with the method, the composition is useful for searching and developing therapeutics for restenosis.
摘要翻译：本文公开了一种用于预防和治疗再狭窄的药物组合物，其包含过氧氧化还原蛋白2（Prx II）蛋白作为活性成分。任选地，组合物可以含有抑制颈动脉，冠状动脉，外周动脉和肾动脉再狭窄的其它活性成分。此外，提供了用于筛选再狭窄治疗剂的组合物和方法。该筛选组合物包含过氧氧化还原酶2基因或蛋白质。与该方法一起，该组合物可用于搜索和开发用于再狭窄的治疗剂。

你已经成功收藏专利！

检索式保存成功!

IPRDB

热门服务

关于我们

友情链接

联系方式